In a patient with four‑vessel coronary artery bypass grafting performed months ago, postoperative paroxysmal atrial fibrillation, chronic congestive heart failure, mild aortic valve stenosis, and hyperlipidemia who is scheduled for a routine diagnostic colonoscopy, should aspirin be held and is the procedure considered low bleeding risk?

Management of Aspirin Before Colonoscopy in Post-CABG Patient with Postoperative PAF

In this patient with remote CABG (performed months ago) and postoperative paroxysmal atrial fibrillation, aspirin should be continued for the colonoscopy, and the procedure is considered low bleeding risk.

Risk Stratification

Procedure Risk

• Diagnostic colonoscopy with biopsy is classified as a low-risk procedure (bleeding risk <1%) 1
• Low-risk endoscopic procedures include all diagnostic procedures with mucosal biopsies 1
• For low-risk procedures, guidelines explicitly state no interruption of antiplatelet agents is needed 1

Thrombotic Risk Assessment

Your patient's thrombotic risk profile requires careful consideration:

• CABG performed months ago (not within 1 month) = Low thrombotic risk 1
• Postoperative PAF (not chronic AF requiring anticoagulation) = Does not elevate thrombotic risk significantly 2, 3
• No drug-eluting stents or recent bare metal stents = Low thrombotic risk 1
• Stable ischemic heart disease without recent acute coronary syndrome = Low thrombotic risk 1

The key distinction here is that postoperative atrial fibrillation after CABG is a common complication (incidence approximately 25%) 2 and typically represents a transient phenomenon rather than a chronic thromboembolic risk requiring long-term anticoagulation 3.

Recommendation for Aspirin Management

Continue aspirin through the colonoscopy without interruption 1:

• For low-risk endoscopic procedures, guidelines recommend against interrupting antiplatelet agents regardless of thrombotic risk 1
• The BSG-ESGE guidelines specifically state that aspirin can be safely continued in patients undergoing low-risk procedures 1
• Mucosal biopsy while continuing antithrombotics has been demonstrated to be safe, with minimal bleeding events reported 1

Important Clinical Caveats

Regarding the Atrial Fibrillation

• Postoperative AF after CABG does not automatically warrant the same thrombotic risk stratification as chronic AF 2, 3
• If the patient is not on chronic anticoagulation for the PAF, this suggests the cardiology team has deemed the thrombotic risk low enough to manage with aspirin alone 4, 5
• The presence of CHF and mild aortic stenosis does not change the low bleeding risk classification of diagnostic colonoscopy 1

Regarding Aspirin in Heart Failure

While there is some controversy about routine aspirin use in chronic heart failure patients (with concerns about worsening outcomes and increased hospitalizations) 6, this should not influence the decision to continue aspirin perioperatively for a low-risk procedure. The thrombotic risk of stopping aspirin, even briefly, outweighs theoretical concerns in the periprocedural period 1.

If This Were a High-Risk Procedure

Had this been a high-risk procedure (polypectomy, EMR >2cm, ESD), the approach would differ 1:

• Aspirin would still typically be continued given the history of CABG 1
• Only ultra-high risk procedures (ESD, large EMR >2cm) would warrant consideration of stopping aspirin 1
• Any decision to stop aspirin would require cardiology consultation 1

Post-Procedure Management

• Resume normal aspirin dosing immediately after the procedure if it were held for any reason 1
• No bridging anticoagulation is needed for this patient 1
• Monitor for delayed bleeding, though risk remains very low with diagnostic colonoscopy 1